These veterinary regulations establish a modern, harmonised approach to the authorisation, manufacture, import, distribution and use of veterinary medicines, with the aim of ensuring consistent quality, enhanced availability and stronger safeguards for animal – and public – health throughout the EU. They replace earlier national-fragmented frameworks and bring a coherent structure under Regulation (EU) 2019/6, enabling veterinary-medicines manufacturers and distributors to operate with greater clarity and predictability.
By embracing the spirit of these veterinary regulations, companies can streamline processes, reduce duplication, and focus on innovation. The shift means fewer regulatory surprises, improved access to EU markets and the confidence to build product strategies around a stable, transparent system of compliance and market access.
Compliance with these veterinary regulations is not optional: it underpins market access, product lifecycle management and regulatory strategy. Whether you’re preparing a dossier, seeking renewal or adapting to changes in supply-chain oversight, understanding and aligning with the veterinary regulations is essential for success in the veterinary medicines sector.
For companies operating in the veterinary medicines sector, these veterinary regulations – rather than being a purely regulatory burden – offer an opportunity to align product strategy with the latest EU framework, enhance market access and reinforce credibility in a regulated environment.
The enactment of today’s EU-wide veterinary regulations marks a pivotal moment for the veterinary medicines sector. It demands a proactive-rather-than-reactive approach to regulatory strategy, product lifecycle management and market access. With the right partner by your side, navigating these veterinary regulations becomes a competitive advantage instead of a compliance burden. Below, you will find how our tailored services guide you step-by-step through each phase of this regulatory journey — from initial strategy through to post-authorisation excellence.
Embracing the demands of the evolving veterinary regulations framework means moving beyond compliance-only thinking and towards strategic advantage. By adopting a forward-looking mindset, your organisation can integrate regulatory planning, product lifecycle optimisation and market access readiness as interconnected elements of a single pathway. Whether it’s adapting documentation, selecting the best regulatory route or ensuring ongoing post-authorisation oversight, every step is an opportunity to build differentiation — guided by clear insights, best-practice templates and tailored support designed for the specificities of the veterinary medicines sector.
Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202
1000 Ljubljana
Slovenia
With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.
Regulatory Affairs
Pharmacovigilance
Medical Consultancy
Quality/GxP
Digital Consultancy
